NCT03161665

Patient and Caregiver Participation Through an Educational Health Information Technology System ("BMT Roadmap") in the Context of Hematopoietic Cell Transplantation

Completed NA Last updated 2 December 2017

What this trial tests

NA trial testing BMT Roadmap in Patients Undergoing Bone Marrow Transplant (BMT) in 40 participants. Completed in 6 January 2017.

Timeline

14 January 2016

Primary endpoint
6 January 2017

6 January 2017

Quick facts

Lead sponsor	University of Michigan Rogel Cancer Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	40
Start date	14 January 2016
Primary completion	6 January 2017
Estimated completion	6 January 2017
Sites	1 location across United States

Drugs / interventions tested

• BMT Roadmap

Conditions studied

• Patients Undergoing Bone Marrow Transplant (BMT) — all drugs for Patients Undergoing Bone Marrow Transplant (BMT) →

Sponsor

University of Michigan Rogel Cancer Center

Who can join

18 and older, any sex, with Patients Undergoing Bone Marrow Transplant (BMT). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hematopoietic cell transplantation (BMT), or commonly referred to as blood and marrow transplantation (BMT), is a potentially life-saving therapy for many malignant and non-malignant conditions. Despite advances over the past decade, which have led to improved outcomes, BMT remains an intense treatment modality often requiring prolonged inpatient--based care. While many patients endure the acute complications of the procedure, it is common for BMT patients and their caregivers to experience increased risk of financial and emotional burden, hospital readmission, and health service utilization. This highlights the importance of active involvement of BMT patients in their own health care (self--efficacy).

Given the intense nature of BMT, however, caregivers also play a critical role in the process and are a necessary component of proceeding with transplant. As such, caregiver activation on behalf of the patient plays a critical role in effective patient--caregiver-provider partnerships, which is increasingly recognized as the optimal model for health care delivery, particularly for those facing life--altering medical treatments. It is essential to develop effective strategies to enhance this partnership. Health information technology (IT)-mediated tools offer the potential to overcome constraints in health care delivery limited by provider time, complicated health information, and financial pressures. Significant gaps in knowledge exist on the use of health IT tools using low- cost and well- accepted delivery platforms in routine inpatient care, especially for high- risk or critically ill populations. We hypothesize that a tablet--based tool displaying personal health information could provide a platform to promote caregiver activation and enhance health communication.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

1. Impact of a health information technology tool addressing information needs of caregivers of adult and pediatric hematopoietic stem cell transplantation patients.
   Fauer AJ, Hoodin F, Lalonde L, Errickson J, et al · · 2019 · cited 26× · PMID 30232587 · DOI 10.1007/s00520-018-4450-4
2. Novel Health Information Technology Tool Use by Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: Longitudinal Quantitative and Qualitative Patient-Reported Outcomes.
   Runaas L, Hoodin F, Munaco A, Fauer A, et al · · 2018 · cited 11× · PMID 30652535 · DOI 10.1200/cci.17.00110